These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 15125823

  • 1. Treating type 2 diabetes: targeting the many causative factors.
    Sutherland JE, Hoehns JD.
    J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
    [No Abstract] [Full Text] [Related]

  • 2. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract] [Full Text] [Related]

  • 3. [Possibilities and limits of oral diabetes therapy].
    Bruneder H.
    Wien Med Wochenschr; 1985 Apr 15; 135(6-7):147-51. PubMed ID: 3890376
    [No Abstract] [Full Text] [Related]

  • 4. Pioglitazone + glimepiride: a combination product to avoid.
    Prescrire Int; 2007 Aug 15; 16(90):145. PubMed ID: 17724836
    [No Abstract] [Full Text] [Related]

  • 5. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H, Miller JL, Rose LI.
    Am Fam Physician; 1995 Nov 15; 52(7):2075-8. PubMed ID: 7484707
    [Abstract] [Full Text] [Related]

  • 6. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
    Prescrire Int; 2007 Aug 15; 16(90):144. PubMed ID: 17726795
    [No Abstract] [Full Text] [Related]

  • 7. [Knack of treatment with oral hypoglycemic drugs in the elderly].
    Komatsu M, Hashizume K.
    Nihon Rinsho; 2006 Jan 15; 64(1):93-8. PubMed ID: 16408454
    [Abstract] [Full Text] [Related]

  • 8. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
    Med Lett Drugs Ther; 2006 Mar 13; 48(1230):22-4. PubMed ID: 16538189
    [No Abstract] [Full Text] [Related]

  • 9. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E, Schnell O.
    Diabetes Care; 2008 Feb 13; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pharmacologic treatment of diabetes].
    De Montigny P, Clerc C, Descarpentries C.
    Perspect Infirm; 2006 Feb 13; 4(2):30-4. PubMed ID: 17184094
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological treatment of type 2 diabetes.
    Hermans MP, Buysschaert M.
    Acta Clin Belg; 2004 Feb 13; 59(2):59-66. PubMed ID: 15224468
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oral combination therapy with thiazolidinediones and sulfonylureas in type 2 diabetes.
    Charbonnel B.
    Int J Clin Pract Suppl; 2007 Jun 13; (153):1-2. PubMed ID: 17594387
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Oral hypoglycemic therapy of diabetes mellitus].
    Montenero P.
    Minerva Med; 1976 Jan 21; 67(3):208-15. PubMed ID: 1250219
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.